Oyster Point Pharma, Inc. OYST
Set alert
11.17 +11.17 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 299.85M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -3.50
- Beta
- 1.28
- Short ratio
- 1.54
- Inst. own
- 87.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2023
- 50-d avg
- 11.07
- 200-d avg
- 7.32
- 1y target
- 15.00
Valuation
P/E -4.6×
FY 2017 5y median -6.4× FY 2021
P/S 19.4×
FY 2017 5y median 0.0× FY 2021
P/B 4.8×
FY 2017 5y median 0.8× FY 2021
P/FCF -5.2×
FY 2017 5y median -7.7× FY 2021
EV/EBITDA -3.9×
FY 2017 5y median -3.9× FY 2021
EV/Sales 15.3×
FY 2017 5y median 0.0× FY 2021
FCF Yield -19.1%
FY 2017 5y median -13.0% FY 2021
Profitability
Gross Margin 93.8%
FY 2017 5y median 0.0% FY 2021
Operating Margin -395.0%
FY 2017 5y median 0.0% FY 2021
Net Margin -425.4%
FY 2017 5y median 0.0% FY 2021
ROE -104.9%
FY 2017 5y median -33.3% FY 2021
ROIC -49.8%
FY 2017 5y median -37.9% FY 2021
ROA -46.9%
FY 2017 5y median -35.6% FY 2021
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2021
Operating Income -36.5%
FY 2017 FY 2021
EPS (diluted) -37.3%
FY 2017 FY 2021
Free Cash Flow -53.7%
FY 2017 FY 2021
Financial Health
Current Ratio 7.5×
FY 2017 5y median 11.2× FY 2021
Quick Ratio 7.3×
FY 2017 5y median 11.2× FY 2021
Debt / Equity 0.9×
FY 2017 5y median 0.0× FY 2021
Net Debt / EBITDA 1.0×
FY 2017 5y median 2.7× FY 2021
Interest Coverage -26.0×
FY 2017 5y median 0.0× FY 2021
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31